Park Dental Partners Inc.
PARK evidence brief
What we can confirm
What it means
What to watch
Prepared research question
What matters most for PARK—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper AI · PARK
Park Dental Partners Inc. (PARK) is a dental services organization that operates through a network of affiliated dental practices, with a focus on organic growth and strategic acquisitions.
Key risk: Negative equity
BioSniper Score
Based on 2 of 6 signals
Limited data coverage
Market Cap
$99.1M
Cash Runway
—
Lead Asset
—
Next Catalyst
—
Financial data as of Jun 30, 2026.
Tracking 7 clinical trials for Park Dental Partners Inc..
Park Dental Partners Inc. (PARK) is a dental services organization that operates through a network of affiliated dental practices, with a focus on organic growth and strategic acquisitions.
- Cash and cash equivalents were $24.4 million as of June 30, 2026 [sec_mda].
- Total revenue for the six months ended June 30, 2026 was $66.2 million [sec].
- Net income for the six months ended June 30, 2026 was $1.3 million [sec].
- Shareholders' equity was -$4.3 million as of June 30, 2026 [sec].
- Total debt was $12.9 million as of June 30, 2026 [sec].
What works
- The company maintains a strong liquidity position with $24.4 million in cash and $15 million unused line of credit as of June 30, 2026 [sec_mda].
- Management believes existing cash and expected cash flows will be sufficient to meet cash needs for at least the next 12 months [sec_mda].
- The company has demonstrated revenue growth, with total revenue of $66.2 million for the six months ended June 30, 2026 [sec].
What to weigh
- Shareholders' equity is negative at -$4.3 million as of June 30, 2026, indicating accumulated deficits exceed equity [sec].
- The company faces regulatory and compliance risks, including state dental corporate practice of dentistry restrictions and HIPAA obligations [sec_mda].
- Reimbursement risk from payers is a noted challenge [sec_mda].
From the filings
Quoted directly from source documents.
Cash position as of June 30, 2026
“Cash and cash equivalents was $24.4 million at June 30, 2026”
SEC MD&A · August 13, 2026
Regulatory and compliance risks
“Regulatory and compliance risk, including state dental corporate practice of dentistry and fee-splitting restrictions, HIPAA and other privacy/cybersecurity obligations”
SEC MD&A · August 13, 2026
Risks & what to watch (3)›
Key risks
- Negative equity — Shareholders' equity of -$4.3M as of June 30, 2026 indicates accumulated losses exceed equity [sec].
- Regulatory compliance — State dental corporate practice restrictions and HIPAA obligations pose ongoing compliance risk [sec_mda].
- Reimbursement risk — Dependence on payer reimbursement exposes the company to policy changes [sec_mda].
What to watch
- Monitor the company's ability to maintain positive net income and improve shareholders' equity [sec].
- Watch for any changes in regulatory environment affecting dental practice management [sec_mda].
- Track cash flow trends and debt levels to assess financial stability [sec_mda].
Sources: Catalysts · SEC filings · SEC MD&A · Generated August 29, 2026 · How we verify sources →
Run Park Dental Partners Inc. through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available Park Dental Partners Inc. facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Evidence & data
Score breakdownBased on 2 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
Profitable (positive operating cash flow)
D/E 5.25 · 36% dilution
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
No insider transactions in the last 180 days
Regulatory
Financials
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
17
Total value held
$10.3M
| Holder | Shares | Value |
|---|---|---|
| kennedy capital management llc | 241,257 | $4.0M |
| heartland advisors inc | 189,539 | $3.2M |
| fmr llc | 48,664 | $817K |
| vanguard capital management llc | 38,620 | $648K |
| sei investments co | 34,766 | $583K |
| citadel advisors llc | 27,444 | $461K |
| geode capital management, llc | 17,887 | $300K |
| vanguard fiduciary trust co | 9,240 | $155K |
| blackrock, inc. | 3,558 | $60K |
| summit securities group llc | 1,000 | $17K |
Showing top 10 of 17 institutional holders of Park Dental Partners Inc.. Open the full 13F history after sign-in.
Short Interest
as of Apr 20, 2026- % of float
- 0.5%
- Days to cover
- 0.5
- Shares short
- 19,698
- Daily short volume (Jun 24, 2026)
- 53.2%
Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →
PARK short interestGovernance
Frequently asked questions
What is the AI investment thesis for Park Dental Partners Inc.?
Park Dental Partners Inc. (PARK) is a dental services organization that operates through a network of affiliated dental practices, with a focus on organic growth and strategic acquisitions.
Who is the CEO of Park Dental Partners Inc.?
Mr. Peter G. Swenson is the chief executive officer of Park Dental Partners Inc. (PARK).
Where is Park Dental Partners Inc. headquartered?
Park Dental Partners Inc. (PARK) is headquartered in Roseville, MN, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.